胃神经内分泌瘤所致巨幼红细胞性贫血(2)
[参考文献]
[1] Yao JC，Hassan M，Phan A，et al. One hundred years after“carcinoid”：epidemiology of and prognostic factors for neuroendocrine tumors in 35，825 cases in the United States[J].J Clin Oncol，2008，26(18)：3063-3072.
[2] Rindi G，Bordi C，Rappel S，et al. Gastric carcinoids and neuroendocrine carcinomas： pathogenesis， pathology， and behavior[J].World J Surg，1996，20(2)：168-172.
[3] Page UF，Jann H，Muller-Nordhorn J，et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropan-creatic neuroendocrine tumors[J].Cancer，2008，113：256-265.
[4] Bosman FT，Carneiro F，Hruban RH，et al.WHO classification of tumours of the digestive system[M].Lyon：IARC Press，2010：26-27.
[5] Olivia YH，Shishir KM，Field FW，et al. Hypergastrinemia，Type 1 Gastric Carcinoid Tumors：Diagnosis and Management[J].J Clin Pathol，2011，29(25)：713-715.
[6] K. Oberg，G.Akerstro，G.Rindi& S. Jelic. Neuroendocrine gastroenteropancreatic tumours：ESMO Clinical Practice Guidelines for diagnosis，treatment and follow-up[J].Annals of Oncology，2010，21(Supplement 5)： 223-227.
[7] D’Elios MM，Appelmelk BJ，Amedei A，et al. Gastric autoimmunity： the role of Helicobacter pylori and molecular mimicry[J].Trends Mol Med，2004，10(7)：316-323.
(收稿日期：2013-08-16), 百拇医药(薛军)
[1] Yao JC，Hassan M，Phan A，et al. One hundred years after“carcinoid”：epidemiology of and prognostic factors for neuroendocrine tumors in 35，825 cases in the United States[J].J Clin Oncol，2008，26(18)：3063-3072.
[2] Rindi G，Bordi C，Rappel S，et al. Gastric carcinoids and neuroendocrine carcinomas： pathogenesis， pathology， and behavior[J].World J Surg，1996，20(2)：168-172.
[3] Page UF，Jann H，Muller-Nordhorn J，et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropan-creatic neuroendocrine tumors[J].Cancer，2008，113：256-265.
[4] Bosman FT，Carneiro F，Hruban RH，et al.WHO classification of tumours of the digestive system[M].Lyon：IARC Press，2010：26-27.
[5] Olivia YH，Shishir KM，Field FW，et al. Hypergastrinemia，Type 1 Gastric Carcinoid Tumors：Diagnosis and Management[J].J Clin Pathol，2011，29(25)：713-715.
[6] K. Oberg，G.Akerstro，G.Rindi& S. Jelic. Neuroendocrine gastroenteropancreatic tumours：ESMO Clinical Practice Guidelines for diagnosis，treatment and follow-up[J].Annals of Oncology，2010，21(Supplement 5)： 223-227.
[7] D’Elios MM，Appelmelk BJ，Amedei A，et al. Gastric autoimmunity： the role of Helicobacter pylori and molecular mimicry[J].Trends Mol Med，2004，10(7)：316-323.
(收稿日期：2013-08-16), 百拇医药(薛军)